Two Cases of Exacerbation of Asthma during Treatment with Enfortumab Vedotin

Enfortumab vedotin is an antibody-drug conjugate against nectin-4 that is recently being used in the management of patients with urothelial carcinoma. The common adverse events include rashes, peripheral neuropathy, and hyperglycemia. Only a few cases of associated respiratory symptoms have been rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Homma, Takamasa, Tanaka, Kuniaki, Takeda, Naoya, Okada, Yu, Torii, Shota, Esaki, Hideki, Sakakibara, Takashi, Takimoto, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601777/
https://www.ncbi.nlm.nih.gov/pubmed/37900848
http://dx.doi.org/10.1159/000534150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601777/
https://www.ncbi.nlm.nih.gov/pubmed/37900848
http://dx.doi.org/10.1159/000534150

Ejemplares similares